𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

✍ Scribed by Elizabeth A. Pomfret; Kenneth Washburn; Christoph Wald; Michael A. Nalesnik; David Douglas; Mark Russo; John Roberts; David J. Reich; Myron E. Schwartz; Luis Mieles; Fred T. Lee; Sander Florman; Francis Yao; Ann Harper; Erick Edwards; Richard Freeman; John Lake


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
303 KB
Volume
16
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


A national conference was held to better characterize the long-term outcomes of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) and to assess whether it is justified to continue the policy of assigning increased priority for candidates with early-stage HCC on the transplant waiting list in the United States. The objectives of the conference were to address specific HCC issues as they relate to liver allocation, develop a standardized pathology report form for the assessment of the explanted liver, develop more specific imaging criteria for HCC designed to qualify LT candidates for automatic Model for End-Stage Liver Disease (MELD) exception points without the need for biopsy, and develop a standardized pretransplant imaging report form for the assessment of patients with liver lesions. At the completion of the meeting, there was agreement that the allocation policy should result in similar risks of removal from the waiting list and similar transplant rates for HCC and non-HCC candidates. In addition, the allocation policy should select HCC candidates so that there are similar posttransplant outcomes for HCC and non-HCC recipients. There was a general consensus for the development of a calculated continuous HCC priority score for ranking HCC candidates on the list that would incorporate the calculated MELD score, alpha-fetoprotein, tumor size, and rate of tumor growth. Only candidates with at least stage T2 tumors would receive additional HCC priority points.


πŸ“œ SIMILAR VOLUMES


Persistent disparities in liver transpla
✍ Anthony S. Robbins; Derrick D. Cox; Lynt B. Johnson; Elizabeth M. Ward πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Prior studies have demonstrated that among patients with hepatocellular carcinoma (HCC), African Americans (AAs) and Asian/Pacific Islanders (APIs) are substantially less likely to undergo liver transplantation (LT) compared with whites. The authors examined whether disp

Use of surveillance for hepatocellular c
✍ Jessica A. Davila; Robert O. Morgan; Peter A. Richardson; Xianglin L. Du; Kather πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended but may not be performed. The extent and determinants of HCC surveillance are unknown. We conducted a population-based United States cohort study of patients over 65 years of age to examine use and determinants

Expanded criteria for liver transplantat
✍ Nicholas Onaca; Gary L. Davis; Robert M. Goldstein; Linda W. Jennings; GΓΆran B. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 344 KB πŸ‘ 2 views

Hepatocellular carcinoma (HCC) is a common indication for liver transplantation (LT). Currently, deceased donor LT is approved by the United Network for Organ Sharing for patients with HCC who meet the Milan criteria of a single tumor up to 5 cm or up to 3 tumors up to 3 cm as determined by imaging

Breast conservation therapy in the Unite
✍ DeAnn Lazovich; Cam C. Solomon; David B. Thomas; Roger E. Moe; Emily White πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of breast conserv